TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has shared an announcement.
Giant Biogene Holding Co., Ltd has announced a board meeting scheduled for August 27, 2025, to review and approve the interim results for the first half of the year and discuss the potential payment of an interim dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential shareholder returns.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$93.70 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, operating with limited liability. It is listed on the Stock Exchange of Hong Kong, focusing on the biogene industry.
Average Trading Volume: 13,894,641
Technical Sentiment Signal: Buy
Current Market Cap: HK$62.39B
For detailed information about 2367 stock, go to TipRanks’ Stock Analysis page.